-Heron Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2019 and Highlights Recent Corporate Updates
SAN DIEGO - Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced financial results for the three and six months ended June 30, 2019and highlighted recent corporate updates.
Recent Corporate Updates
Pain Management Franchise
Complete Response Letter Received from the FDA Regarding the NDA for HTX...